SCHEMBL4370619

SCHEMBL4370619

O=C(NSc1ccc(N2CCCCC2)c(C(F)(F)F)c1)NC(=O)c1cc2ccccc2o1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.50
RAB9A P51151 7/20 0.50
ALDH1A1 P00352 5/20 0.50
KMT2A Q03164 5/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
MAPT P10636 3/20 0.50
NPSR1 Q6W5P4 3/20 0.50
KDM4E B2RXH2 2/20 0.50
TP53 P04637 2/20 0.50
ATM Q13315 2/20 0.50
HTT P42858 1/20 0.50
S1PR1 P21453 1/20 0.44
MEN1 O00255 3/20 0.43
HSD17B10 Q99714 2/20 0.43
LMNA P02545 2/20 0.43
POLB P06746 1/20 0.43
HPGD P15428 2/20 0.42
MAPK1 P28482 2/20 0.42
TSHR P16473 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13956855 0.84 S1PR1 (0.61) NPC1RAB9AALDH1A1KMT2ASMN1; SMN2
SCHEMBL4370624 0.79 NPC1 (0.62) NPC1RAB9AALDH1A1KMT2ASMN1; SMN2
SCHEMBL27639731 0.76 NOTUM (0.43) HTTS1PR1SRPK1
SCHEMBL4518242 0.75 NPC1 (0.43) NPC1RAB9AALDH1A1KMT2ASMN1; SMN2
SCHEMBL4362127 0.72 RAB9A (0.42) NPC1RAB9AALDH1A1KMT2ASMN1; SMN2
SCHEMBL4538068 0.70 SMN1; SMN2 (0.49) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL4369705 0.70 NPC1 (0.47) NPC1RAB9AALDH1A1KMT2ASMN1; SMN2
SCHEMBL3634482 0.70 SMN1; SMN2 (0.51) NPC1RAB9AALDH1A1KMT2ASMN1; SMN2
SCHEMBL4360383 0.69 SMN1; SMN2 (0.47) NPC1RAB9AALDH1A1KMT2ASMN1; SMN2
SCHEMBL13956757 0.69 NPC1 (0.66) NPC1RAB9AALDH1A1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476686-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2009-01-13 US claimed
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication CHEN DAWEI 2006-01-19 US claimed
US-20040138205-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. 2004-07-15 US claimed
US-7476686-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2009-01-13 US disclosed
US-7094807-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2006-08-22 US disclosed
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication CHEN DAWEI 2006-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138205-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication NAT1, PIGS, TPMT NPC1 107/4885RAB9A 2176/4885ALDH1A1 310/4885
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication NAT1, PIGS, SLC10A1 NPC1 151/4885RAB9A 2273/4885ALDH1A1 221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.